• The Journal of Korean Institute of Communications and Information Sciences
• /
• v.15 no.10
• /
• pp.819-828
• /
• 1990

• Journal of the Institute of Electronics Engineers of Korea SD
• /
• v.43 no.3 s.345
• /
• pp.40-47
• /
• 2006

The finite-field multiplication can be applied to the elliptic curve cryptosystems. However, an efficient algorithm and the hardware design are required since the finite-field multiplication takes much time to compute. In this paper, we propose a radix-4 systolic multiplier on $GF(2^m)$ with comparative area and performance. The algorithm of the proposed standard-basis multiplier is mathematically developed to map on low-cost systolic cells, so that the proposed systolic architecture is suitable for VLSI design. Compared to the bit-parallel, bit-serial and systolic multipliers, the proposed multiplier has relatively effective high performance and low cost. We design and synthesis $GF(2^{193})$ finite-field multiplier using Hynix $0.35{\mu}m$ standard cell library and the maximum clock frequency is 400MHz.

• Journal of the Korean Society of Fisheries and Ocean Technology
• /
• v.26 no.3
• /
• pp.295-302
• /
• 1990

In this paper, a methodology for the automatic design of the optimal systolic arrays is proposed. Algorithm transformation is the main mathematical tool on which this methodology is based. Also, technique for partitioning algorithm into systolic arrays is presented. Algorithm partitioning is essential when the size of the computational problem is larger than the size of the array. This study results in (a) reduction of the design time of systolic arrays for given algorithms, (b) CRT display of the structures of systolic arrays, and (c) automatic designing of the optimal systolic array by the criteria such as the number of processing elements, bands, and communication paths. The procedure for these results was programmed using HP BASIC language on HP-9836 computer.

• Clinics in Shoulder and Elbow
• /
• v.27 no.1
• /
• pp.11-17
• /
• 2024

Background: Rotator cuff tears are often associated with synovitis, but the ability of noninvasive ultrasonography to predict the severity of synovitis remains unclear. We investigated whether ultrasound parameters, namely peak systolic velocity in the anterior humeral circumflex artery and Doppler activity in the glenohumeral joint and subacromial space, reflect synovitis severity. Methods: A total of 54 patients undergoing arthroscopic rotator cuff repair were selected. Doppler ultrasound was used to measure peak systolic velocity in the anterior humeral circumflex artery and Doppler activity in the glenohumeral joint and subacromial space, and these values were compared with the intraoperative synovitis score in univariate and multivariate analyses. Results: Univariate analyses revealed that tear size, peak systolic velocity in the anterior humeral circumflex artery, and Doppler activity in the glenohumeral joint were associated with synovitis in the glenohumeral joint (P=0.02, P<0.001, P=0.02, respectively). In the subacromial space, tear size, peak systolic velocity in the anterior humeral circumflex artery, and Doppler activity in the subacromial space were associated with synovitis severity (P=0.02, P<0.001, P=0.02, respectively). Multivariate analyses indicated that tear size and peak systolic velocity in the anterior humeral circumflex artery were independently associated with synovitis scores in both the glenohumeral joint and the subacromial space (all P<0.05). Conclusions: These findings demonstrate that tear size and peak systolic velocity in the anterior humeral circumflex artery, which can both be measured noninvasively, are useful indicators of synovitis severity.

• The Korean Journal of Nuclear Medicine
• /
• v.34 no.6
• /
• pp.487-496
• /
• 2000

Purpose: The aim of this study is to investigate the reproducibility of the quantitative assessment of segmental wall motion and systolic thickening provided by an automatic quantitation algorithm. Materials and Methods: Tc-99m-MIBI gated myocardial SPECT with dipyridamole stress was performed in 31 patients with known or suspected coronary artery disease (4 with single, 6 with two, 11 with triple vessel disease; ejection fraction $51{\pm}14%$) twice consecutively in the same position. Myocardium was divided into 20 segments. Segmental wall motion and systolic thickening were calculated and expressed in mm and % increase respectively, using $AutoQUANT^{TM}$ software. The reproducibility of this quantitative measurement of wall motion and thickening was tested. Results: Correlations between repeated measurements on consecutive gated SPECT were excellent for wall motion (r=0.95) and systolic thickening (r=0.88). On Bland-Altman analysis, two standard deviation was 2 mm for repeated measurement of segmental wall motion, and 20% for that of systolic thickening. The weighted kappa values of repeated measurements were 0.807 for wall motion and 0.708 for systolic thickening. Sex, perfusion, or segmental location had no influence on reproducibility. Conclusion: Segmental wall motion and systolic thickening quantified using $AutoeUANT^{TM}$ software on gated myocardial SPECT offers good reproducibility and is significantly different when the change is more than 2 mm for wall motion and more than 20% for systolic thickening.

• 한국전산유체공학회:학술대회논문집
• /
• 2006.05a
• /
• pp.174-177
• /
• 2006

• Proceedings of the Korean Information Science Society Conference
• /
• 2000.10a
• /
• pp.590-592
• /
• 2000

Operator-level optimization of a systolic array for Montgomery Modular Multiplication(MMM) algorithm is presented in thin paper. The proposed systolic array is faster than that of C.D. Walter by 40%. Compared with J.B. Shin et al.'s, it is 25% faster.

• The Journal of Korean Institute of Communications and Information Sciences
• /
• v.29 no.8C
• /
• pp.1047-1054
• /
• 2004

In this paper, we present two systolic arrays for computing multiplications in CF(2$\^$m/) generated by an irreducible all one polynomial (AOP). The proposed two systolic mays have parallel-in parallel-out structure. The first systolic multiplier has area complexity of O(㎡) and time complexity of O(1). In other words, the multiplier consists of m(m+1)/2 identical cells and produces multiplication results at a rate of one every 1 clock cycle, after an initial delay of m/2+1 cycles. Compared with the previously proposed related multiplier using AOP, our design has 12 percent reduced hardware complexity and 50 percent reduced computation delay time. The other systolic multiplier, designed for cryptographic applications, has area complexity of O(m) and time complexity of O(m), i.e., it is composed of m+1 identical cells and produces multiplication results at a rate of one every m/2+1 clock cycles. Compared with other linear systolic multipliers, we find that our design has at least 43 percent reduced hardware complexity, 83 percent reduced computation delay time, and has twice higher throughput rate Furthermore, since the proposed two architectures have a high regularity and modularity, they are well suited to VLSI implementations. Therefore, when the proposed architectures are used for GF(2$\^$m/) applications, one can achieve maximum throughput performance with least hardware requirements.

• Korean Journal of Veterinary Research
• /
• v.37 no.3
• /
• pp.669-685
• /
• 1997

The present study was performed to evaluate the effects of xylazine and tiletamine + zolazepam on echocardiograms before and after experimental myocardial infarctions in clinically normal dogs taken preliminary examinations related to cardiac function. The results are as follows. With xylazine administration, left ventricle end-diastolic dimension, left ventricle end-systolic dimension, left atrium/aorta, ejection time and velocity of circumferential fiber shortening increased and mitral valve CD slope, % delta D decreased(p<0.01). In tiletamine+zolazepam administered group, interventricular septum amplitude(p<0.01), mitral valve DE slope(p<0.05) and ejection time(p<0.01) decreased and left atrium/aorta, ejection time also decreased compared with xylazine group(p<0.01). In 48 hours after experimental myocardial infarction group, anterior aortic wall amplitude decreased compared with control, xylazine, tiletamine + zolazepam group, respectively(p<0.01). Posterior aortic wall amplitude decreased compared with control(p<0.01). Left ventricle end systolic dimension increased compared with control and tiletamine + zolazepam group, respectively(p<0.01). Left ventricular posterior wall end systolic dimension decreased compared with control(p<0.01). Left ventricular posterior wall amplitude decreased compared with control and tiletamine+zolazepam group(p<0.01). Left atrium/aorta decreased compared with xylazine group(p<0.01). % thickening left ventricular posterior wall decreased compared with control(p<0.05). % delta D decreased compared with control and tiletamine+zolazepam group(p<0.01). Ejection time decreased compared with xylazine(p<0.01). Velocity of circumferential fiber shortening increased compared with control and tiletamine + zolazepam group(p<0.01). With xylazine administration 48 hours after experimental myocardial infarction, anterior aortic wall amplitude, posterior aortic wall amplitude decreased compared with control(p<0.01). Left ventricle end-diastolic dimension increased compared with control(p<0.01). Left ventricle end-systolic dimension increased compared with control and tiletamine + zolazepam group, respectively(p<0.01). Left ventricular posterior wall end-systolic dimension and left ventricular posterior wall end-diastolic dimension decreased compared with control(p<0.01). Left atrium/aorta decreased compared with xylazine group(p<0.01). % thickening left ventricular posterior. wall(p<0.05) and % delta D(p<0.01) decreased compared with control. Velocity of circumferential fiber shortening increased compared with tiletamine + zolazepam group(p<0.01). With tiletamine + zolazepam administration 48 hours after experimental myocardial infarction, anterior aortic wall amplitude decreased compared with control, xylazine and tiletamine+zolazepam group, respectively(p<0.01). Posterior aortic wall amplitude decreased compared with control(p<0.01). Left ventricle end-systolic dimension increased compared with control and tiletamine+zolazepam group(p<0.01). Left ventricular posterior wall end-systolic dimension, left ventricular posterior wall end-diastolic dimension and interventricular septum amplitude decreased compared with control(p<0.01). Left atrium/aorta decreased compared with xylazine group(p<0.01). % delta D decreased compared with control and tiletamine + zolazepam group(p<0.01). Ejection time decreased compared with xylazine group and velocity of circumferential fiber shortening increased compared withtiletamine+zolazepam group(p<0.01). Conclusively, echocardiography was proved to be a useful, diagnostic, non-invasive and simple method for establishing the diagnosis of myocardial infarction and evaluating the effects of drug on cardiac function before and after myocardial infarction.

• The Korean Journal of Nuclear Medicine
• /
• v.21 no.2
• /
• pp.175-182
• /
• 1987

For measurement of ventricular performance, ejection fraction (EF) has gained wide acceptance. But EF is influenced not only by changes in muscle function but also by changes in cardiac loading conditions. In case of valvular heart disease which is variable in loading conditions, EF cannot be reliable as an index of myocardial contractility. The end systolic pressure (ESP)-end systolic volume (ESV) relation, howver, is known to represent myocardial contractility, independent of changes in loading conditions. Similar results can be obtained by using peak-systolic pressure (PSP) instead of ESP. To evaluate the utility of the peak systolic pressure-end systolic volume index (PSP-ESVI) relation as an index of myocardial function, we measured $PSP&ESVI$ in 19 partents with coronary artery disease before $(PSP_1\;&\;ESVI_1)$ and after $(PSP_2\;&\;ESVI_2)$ sublingual administration of nitroglycerin. PSP was measured with standard mercury sphygmomanometer during gated blood pool scintigraphic study. ESVI was measured by count derived method after attenuation correction. $PSP_2\;&\;ESVI_2$ measurement was started when the fall of PSP was greater than 5 mmHg after 7-14 minutes post-administration of nitroglycerin. Mean values $({\pm}S.D.)$ of $PSP_1\;&\;ESVI_1$ was $124.9({\pm}20.7)mmHg\;&\;59.4({\pm}39.9)ml/M^2$. Mean values $({\pm}S.D)$ of $PSP_2\;&\;ESVI_2$, was $113.2({\pm}19.9)mmHg\;&\;37.5({\pm}26.1)ml/M^2$. There was a significant difference between mean values of $PSP_1\;&\;PSP_2$, (p<0.01), and mean values of $ESVI_1\;&\;ESVI_2$, (p<0.01). $PSP_1-PSP_2/ESV_1-ESVI_2,\;PSP_1/ESVI_1$ and EF were in the range of 0.14-5.19 mmHg/ml/$M^2$, 0.67-7.68 mmHg/ml/$M^2$ and 10.8%-74.5% respectively. $PSP_1-PSP_2/ESVI_1-ESVI_2$, and EF showed exponential correlation (r=0.85, P<0.01). The correlation coefficient between $PSP_1/ESVI_1$ and EF was 0.73(p<0.01). With the above results, we suggest that $PSP_1-PSP_2/ESVI_1-ESVI_2$, and $PSP_1/ESVI_1$, can be used as an index of myocardial function.